ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
PDG5 BUDGET IMPACT ANALYSIS OF CLADRIBINE IN HIGH DISEASE ACTIVITY RELAPSE REMITTING MULTIPLE SCLEROSIS IN ARGENTINA
Value in Health Regional Issues
◽
10.1016/j.vhri.2019.08.175
◽
2019
◽
Vol 19
◽
pp. S32
Author(s):
A. Palacios
◽
N. Espinola
◽
V. Saenz
◽
M. Romano
◽
A. Bardach
◽
...
Keyword(s):
Multiple Sclerosis
◽
Disease Activity
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
High Disease Activity
◽
Remitting Multiple Sclerosis
Download Full-text
Related Documents
Cited By
References
Alemtuzumab Budget Impact Analysis in Relapsing-Remitting Multiple Sclerosis in the US
Value in Health
◽
10.1016/j.jval.2015.03.1637
◽
2015
◽
Vol 18
(3)
◽
pp. A280
Author(s):
C. Celestin
◽
T. Wandstrat
◽
C.I. Coleman
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
The Us
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy
Value in Health
◽
10.1016/j.jval.2017.08.1930
◽
2017
◽
Vol 20
(9)
◽
pp. A720
Author(s):
F Demma
◽
G Casamassima
◽
E Cocco
◽
R Di Turi
◽
D Paolicelli
◽
...
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy
Value in Health
◽
10.1016/j.jval.2015.09.2619
◽
2015
◽
Vol 18
(7)
◽
pp. A700-A701
◽
Cited By ~ 1
Author(s):
G Furneri
◽
C Marchesi
◽
L Santoni
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients: 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective
Value in Health
◽
10.1016/j.jval.2013.08.1814
◽
2013
◽
Vol 16
(7)
◽
pp. A621
Author(s):
A.M. Nishikawa
◽
L. Paladini
◽
A.L. Liamas
◽
C.C. Bueno
◽
O.A.C. Clark
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Payer Perspective
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Public Payer
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Budget Impact Analysis of Cladribine Tablets for Treatment Of Patients with Relapsing-Remitting Multiple Sclerosis In Bulgaria
Value in Health
◽
10.1016/j.jval.2018.04.1395
◽
2018
◽
Vol 21
◽
pp. S205
Author(s):
S Djambazov
◽
G Slavchev
◽
T Dineva
◽
P Panayotov
◽
T Vekov
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Budget Impact Analysis of Cladribine Tablets in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients in Kingdom of Saudi Arabia
Multiple Sclerosis and Related Disorders
◽
10.1016/j.msard.2019.11.020
◽
2020
◽
Vol 37
◽
pp. 101545
Author(s):
Saeed Abdullah Bohlega
◽
Hajer Al-Mudaiheem
◽
Mansour Alhowimel
◽
Koshu Mahajan
◽
Omneya Mohamed
◽
...
Keyword(s):
Multiple Sclerosis
◽
Saudi Arabia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Kingdom Of Saudi Arabia
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
PND37 BUDGET IMPACT ANALYSIS OF ALEMTUZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN HEALTHCARE SOCIAL SECURITY (ESSALUD) IN PERU
Value in Health
◽
10.1016/j.jval.2020.04.930
◽
2020
◽
Vol 23
◽
pp. S265
Author(s):
M. Moreno
◽
J. Arce
◽
A. Cruz
◽
R. Carpio Farro
Keyword(s):
Multiple Sclerosis
◽
Social Security
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis
Value in Health
◽
10.1016/j.jval.2014.08.872
◽
2014
◽
Vol 17
(7)
◽
pp. A393
Author(s):
M. Ruggeri
◽
A. D'Ausilio
◽
R. Lo Muto
◽
S. Cottone
◽
A. Ghezzi
◽
...
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
PND9 BUDGET IMPACT ANALYSIS OF CLADRIBINE COMPARED TO THE CURRENT COVERAGE SCHEME IN CHILE TO TREAT PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS
Value in Health Regional Issues
◽
10.1016/j.vhri.2019.08.339
◽
2019
◽
Vol 19
◽
pp. S60
Author(s):
C. Balmaceda
◽
M.A. Espinoza
◽
R. Rojas
Keyword(s):
Multiple Sclerosis
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Highly Active
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
PND8 COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF SUBCUTANEOUS INTERFERON BETA-1A FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Value in Health
◽
10.1016/s1098-3015(10)74802-6
◽
2009
◽
Vol 12
(7)
◽
pp. A366-A367
Author(s):
O Espallardo
◽
C Crespo
◽
C Polanco
◽
D Nieves
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Impact Analysis
◽
Interferon Beta
◽
Budget Impact
◽
Budget Impact Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close